Pharmaceutical Preparations: average industry financial ratios for U.S. listed companies
Industry: 2834 - Pharmaceutical Preparations Measure of center:| Financial ratio | Year | |||||
|---|---|---|---|---|---|---|
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| Solvency Ratios | ||||||
| Debt ratio | 0.29 | 0.34 | 0.40 | 0.43 | 0.47 | 0.50 |
| Debt-to-equity ratio | 0.27 | 0.27 | 0.36 | 0.32 | 0.30 | 0.26 |
| Interest coverage ratio | -21.20 | -20.50 | -16.16 | -19.19 | -16.39 | -17.93 |
| Liquidity Ratios | ||||||
| Current Ratio | 5.68 | 5.36 | 3.93 | 3.81 | 3.24 | 3.14 |
| Quick Ratio | 3.73 | 3.72 | 2.96 | 2.78 | 2.80 | 2.56 |
| Cash Ratio | 4.77 | 4.59 | 3.17 | 2.81 | 2.52 | 2.32 |
| Profitability Ratios | ||||||
| Profit margin | -293.9% | -268.3% | -263.4% | -271.6% | -250.7% | -274.7% |
| ROE (Return on equity), after tax | -61.6% | -73% | -78.1% | -88.4% | -98.4% | -88.2% |
| ROA (Return on assets) | -39.2% | -46.3% | -48.6% | -47.5% | -52.4% | -53% |
| Gross margin | 73.7% | 71.7% | 69.1% | 66.5% | 65.1% | 60.4% |
| Operating margin (Return on sales) | -160.4% | -160.4% | -139.1% | -233.3% | -114.9% | -128.6% |
| Activity Ratios | ||||||
| Asset turnover (days) | 2724 | 2339 | 1982 | 2081 | 1820 | 1717 |
| Receivables turnover (days) | 65 | 65 | 65 | 60 | 59 | 59 |
| Inventory turnover (days) | 179 | 170 | 164 | 163 | 160 | 149 |
| Price Ratios | ||||||
| Dividend Payout Ratio | 0.29 | -0.01 | 0.00 | -0.02 | 0.00 | 0.00 |